No. 24-456
Boehringer Ingelheim Pharmaceuticals, Inc., et al. v. Beth Bacher, Representative for Paul Bacher, Deceased, et al.
Tags: class-action-fairness-act federal-removal mass-action statutory-interpretation subject-matter-jurisdiction trial-consolidation
Latest Conference:
2025-01-24
Question Presented (from Petition)
Whether plaintiffs' intent matters in assessing if plaintiffs have "proposed" a joint trial of the claims of 100 or more persons pursuant to 28 U.S.C. § 1332(d)(11)?
Question Presented (AI Summary)
Whether plaintiffs' intent matters in assessing if plaintiffs have 'proposed' a joint trial of the claims of 100 or more persons pursuant to 28 U.S.C. § 1332(d)(11)?
Docket Entries
2025-01-27
Petition DENIED.
2025-01-08
DISTRIBUTED for Conference of 1/24/2025.
2025-01-06
Reply of Boehringer Ingelheim Pharmaceuticals, Inc., et al. submitted.
2025-01-06
Reply of petitioners Boehringer Ingelheim Pharmaceuticals, Inc., et al. filed. (Distributed)
2024-12-20
Brief of Beth Bacher, Representative for Paul Bacher (Deceased), et al. in opposition submitted.
2024-12-20
Brief of respondents Beth Bacher, Representative for Paul Bacher (Deceased), et al. in opposition filed.
2024-12-20
Brief of respondents Beth Bacher, et al. in opposition filed.
2024-10-30
Motion to extend the time to file a response is granted and the time is extended to and including December 23, 2024. See Rule 30.1.
2024-10-28
Motion to extend the time to file a response from November 22, 2024 to December 22, 2024, submitted to The Clerk.
2024-10-21
Petition for a writ of certiorari filed. (Response due November 22, 2024)
Attorneys
Beth Bacher, Representative for Paul Bacher (Deceased), et al.
John Anthony Bruegger — Parafinczuk Wolf, P.A., Respondent
Boehringer Ingelheim Pharmaceuticals, Inc., et al.
Daniel S. Pariser — Arnold and Porter Kaye Scholer LLP, Petitioner